Prot# CYC682-06-05 (A2): A Randomized Phase II Study of Oral Sapacitabine in Patients with Advanced Cutaneous T-Cell Lymphoma

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date10/7/08 → 10/7/11

    Funding

    • Cyclacel Pharmaceuticals, Inc. (CYC682-06-05 (A2))
    View all
    View less